Article Text
Abstract
Introduction Nicotine pouches are small, permeable pouches containing nicotine. The nicotine may either be derived from tobacco plants or synthetically produced. Nicotine pouches are available worldwide, but little is known as to how various countries regulate these products. This study summarises nicotine pouch regulatory policies across 67 countries.
Methods This research summarises insights obtained through active policy surveillance work in which we requested information on the availability of nicotine pouches and applicable policies and analysed responses from representatives of 67 countries (representatives included subject matter experts in government or civil society organisations). These countries span all WHO regions.
Results We found significant variation in how countries classify nicotine pouches, with many countries’ current regulatory approach failing to regulate nicotine pouches that used synthetic nicotine. We found 34 countries regulate nicotine pouches with 23 of these countries’ policies encompassing synthetic nicotine. Countries regulating both synthetic and tobacco-derived nicotine pouches generally (1) rely on existing policies for tobacco products and/or medicines or (2) have developed new policies or regulatory classifications that specify nicotine as the substance at issue rather than linking policies solely to tobacco.
Conclusion Our work offers novel insight into nicotine pouch markets and national regulatory approaches. Policy approaches vary from not regulating nicotine pouches at all to banning both forms of nicotine pouches. Policies used by countries regulating both tobacco-derived and synthetic nicotine pouches offer a roadmap for how other jurisdictions can add effective guardrails to the use of these and other non-medicinal nicotine products.
- nicotine
- tobacco industry
- public policy
- global health
Data availability statement
All data relevant to the study are included in the article or are publicly available. The data for this paper were primarily from country laws, which we cite in the paper. We provide citations for, and links to, the relevant laws. Additional data obtained directly from in-country contacts are included in the article.
Statistics from Altmetric.com
Data availability statement
All data relevant to the study are included in the article or are publicly available. The data for this paper were primarily from country laws, which we cite in the paper. We provide citations for, and links to, the relevant laws. Additional data obtained directly from in-country contacts are included in the article.
Footnotes
Twitter @ryan_david
Contributors The paper was conceptualised by RDK and LA. Policy collection and review were conducted by MD and LA. MD authored the first draft. All authors reviewed and made contributions to the final version. MD is the guarantor.
Funding Funding was provided by Bloomberg Philanthropies' Bloomberg Initiative to Reduce Tobacco Use. MD was supported by a grant from the US Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health to the Johns Hopkins Education and Research Center for Occupational Safety and Health (award number T42 OH0008428).
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.